Metabolic response to enzalutamide (ENZ), assessed by choline positron emission tomography (cPET), in castration resistant prostate cancer (CRPC) patients (pts): Updated results of a monoinstitutional prospective study.

Prospective Study ◽

Metabolic Response ◽

Emission Tomography ◽

Castration Resistant ◽

Positron Emission

Volume reduction and metabolic response of primary prostate cancer to enzalutamide (ENZ) : A metabolic evaluation by 18F-fluorocholine-positron emission tomography/computerized tomography (18F-FCH PET/CT) in castration resistant prostate cancer (CRPC) patients (pts).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e16056 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e16056-e16056

Author(s):

Orazio Caffo ◽

Francesca Maines ◽

Davide Donner ◽

Antonello Veccia ◽

Franca Chierichetti ◽

...

Keyword(s):

Prostate Cancer ◽

Metabolic Response ◽

Emission Tomography ◽

Metabolic Evaluation ◽

Castration Resistant ◽

Positron Emission ◽

Primary Prostate Cancer ◽

Pet Ct

Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer

International Urology and Nephrology ◽

10.1007/s11255-019-02233-y ◽

2019 ◽

Vol 51 (10) ◽

pp. 1763-1769 ◽

Cited By ~ 2

Author(s):

Keina Nozaki ◽

Taketo Kawai ◽

Tetsuya Fujimura ◽

Hotaka Matsui ◽

Taro Teshima ◽

...

Keyword(s):

Prostate Cancer ◽

Computed Tomography ◽

Local Therapy ◽

Emission Tomography ◽

Castration Resistant ◽

Positron Emission

The Relationship Between Total Lesion Activity on 18F Choline Positron Emission Tomography-Computed Tomography and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Bone Metastases Treated with 223Radium

Cancer Biotherapy & Radiopharmaceuticals ◽

10.1089/cbr.2019.3188 ◽

2020 ◽

Vol 35 (6) ◽

pp. 398-403 ◽

Cited By ~ 3

Author(s):

Luca Filippi ◽

Pietro Basile ◽

Orazio Schillaci ◽

Oreste Bagni

Keyword(s):

Prostate Cancer ◽

Computed Tomography ◽

Clinical Outcome ◽

Bone Metastases ◽

Emission Tomography ◽

Castration Resistant ◽

Positron Emission ◽

The Relationship

18F-fluorocholine positron emission tomography/computed tomography for early outcome prediction in metastatic castration-resistant prostate cancer patients treated with enzalutamide: A proof-of-principle study.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e16040 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e16040-e16040

Author(s):

Ugo De Giorgi ◽

Paola Caroli ◽

Emanuela Scarpi ◽

Vincenza Conteduca ◽

Salvatore Luca Burgio ◽

...

Keyword(s):

Prostate Cancer ◽

Computed Tomography ◽

Outcome Prediction ◽

Emission Tomography ◽

Early Outcome ◽

Castration Resistant ◽

Positron Emission ◽

Proof Of Principle

Re: Positron Emission Tomography/Computed Tomography-based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2017.12.004 ◽

2018 ◽

Vol 73 (4) ◽

pp. 639-640 ◽

Cited By ~ 1

Author(s):

Bernardo Rocco ◽

Ahmed Eissa ◽

Giampaolo Bianchi

Keyword(s):

Prostate Cancer ◽

Computed Tomography ◽

Prognostic Biomarker ◽

Receptor Expression ◽

Emission Tomography ◽

Castration Resistant ◽

Positron Emission ◽

Glycolytic Activity

Prognostic and predictive role of 18F-choline (c) positron emission tomography (PET) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) treated with enzalutamide (ENZ) after docetaxel (DOC) failure

Annals of Oncology ◽

10.1093/annonc/mdv341.26 ◽

2015 ◽

Vol 26 ◽

pp. vi60

Author(s):

A. Veccia ◽

F. Maines ◽

O. Caffo ◽

C. Trentin ◽

D. Donner ◽

...

Keyword(s):

Prostate Cancer ◽

Emission Tomography ◽

Castration Resistant ◽

Positron Emission ◽

Predictive Role

Prostate-specific membrane antigen positron-emission tomography (PSMA-PET) in high-risk nonmetastatic castration-resistant prostate cancer (nmCRPC) SPARTAN-like patients (pts) negative by conventional imaging

European Urology Supplements ◽

10.1016/s1569-9056(19)30510-x ◽

2019 ◽

Vol 18 (1) ◽

pp. e698-e699 ◽

Cited By ~ 2

Author(s):

B.A. Hadaschik ◽

M. Weber ◽

A. Iravani ◽

M.S. Hofman ◽

J. Calais ◽

...

Keyword(s):

Prostate Cancer ◽

Emission Tomography ◽

Prostate Specific Membrane Antigen ◽

Conventional Imaging ◽

Castration Resistant ◽

Positron Emission ◽

Psma Pet ◽

Specific Membrane

Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-19-1050 ◽

2019 ◽

Vol 25 (24) ◽

pp. 7448-7454 ◽

Cited By ~ 36

Author(s):

Wolfgang P. Fendler ◽

Manuel Weber ◽

Amir Iravani ◽

Michael S. Hofman ◽

Jérémie Calais ◽

...

Keyword(s):

Prostate Cancer ◽

Emission Tomography ◽

Prostate Specific Membrane Antigen ◽

Castration Resistant ◽

Positron Emission ◽

Specific Membrane

Positron Emission Tomography/Computed Tomography–Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer

JAMA Oncology ◽

10.1001/jamaoncol.2017.3588 ◽

2018 ◽

Vol 4 (2) ◽

pp. 217 ◽

Cited By ~ 32

Author(s):

Josef J. Fox ◽

Somali C. Gavane ◽

Estelle Blanc-Autran ◽

Sadek Nehmeh ◽

Mithat Gönen ◽

...

Keyword(s):

Prostate Cancer ◽

Computed Tomography ◽

Prognostic Biomarker ◽

Receptor Expression ◽

Emission Tomography ◽

Castration Resistant ◽

Positron Emission ◽

Glycolytic Activity

Re: Prostate-specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2020.04.005 ◽

2020 ◽

Vol 78 (2) ◽

pp. 292-293

Author(s):

Jochen Walz

Keyword(s):

Prostate Cancer ◽

Emission Tomography ◽

Prostate Specific Membrane Antigen ◽

Castration Resistant ◽

Positron Emission ◽

Specific Membrane